Open AccessPsychologyMedicine

A. Koyuncu, E. Ince, E. Ertekin, R. Tükel

2019.4.2Drugs in Context

DOI: 10.7573/dic.212573

tlooto Summary

In this review, major psychiatric comorbidities that can be encountered over the course of SAD as well asComorbidity associated diagnostic and therapeutic challenges will be discussed.

Abstract

Comorbid disorders are highly prevalent in patients with social anxiety disorder, occurring in as many as 90% of patients. The presence of comorbidity may affect the course of the disease in several ways such as comorbidity in patients with social anxiety disorder (SAD) is related to earlier treatment-seeking behavior, increased symptom severity, treatment resistance and decreased functioning. Moreover, comorbidities cause significant difficulties in nosology and diagnosis, and may cause treatment challenges. In this review, major psychiatric comorbidities that can be encountered over the course of SAD as well as comorbidity associated diagnostic and therapeutic challenges will be discussed.

Citation format

KOYUNCU, A., et al. Comorbidity in social anxiety disorder: Diagnostic and therapeutic challenges. Drugs in Context, 2019, 8.